glp 1 six in 1 GLP-1 Medications and Heart Health Benefits | Baylor Scott & White Health posted on the topic My Life on GLP-1: Six
Description
Daily insulin users: every 2-4 weeks
ESG has been shown to influence metabolic pathways, as demonstrated in the MERIT study (The Lancet, 2022), suggesting may offer similar metabolic benefits as a manual ESG approach
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases
This review summarises the clinical evidence for cardiovascular protection with use of GLP-1RAs and the main mechanisms underlying this effect
